Mapping tool highlights NIH-funded small business successes
On Aug. 13, 2020, the NIH announced a new interactive mapping tool that showcases just some of the…
-
-
Biotechnology | COVID-19 | Influenza | NIH
Celdara Medical announced receipt of NIH funding for pandemic influenza antiviral development
On Aug. 12, 2020, Celdara Medical announced that the NIH had awarded a Small Business Innovation Research (SBIR)…
-
COVID-19 | Diagnostics | Medical Device | NIH
NIH harnessed AI for COVID-19 diagnosis, treatment, and monitoring
On Aug. 5, 2020, the National Institutes of Health (NIH) announced it had launched the Medical Imaging and…
-
NIH launched clinical trial to test antibody treatment in hospitalized COVID-19 patients
On Aug. 4, 2020, the NIH announced that patients admitted with COVID-19 at select hospitals may now volunteer…
-
NIH delivered new COVID-19 testing technologies to meet US demand
On Jul. 31, 2020, the NIH announced that it had invested $248.7 million in new technologies to address…
-
Biotechnology | COVID-19 | NIH
Quidel received NIH contract for $71 million to expand manufacturing capacity for Sofia SARS-CoV-2 antigen test for diagnosis of COVID-19
On Jul. 31, 2020, Quidel announced a preliminary contract with the NIH to support the expansion of its…
-
COVID-19 | Diagnostics | NIH
Mesa Biotech announced $154 million funding from the NIH for Accelerated scale-up and deployment
On Jul. 31, 2020, Mesa Biotech announced it had been awarded a contract up to $15.4 million from…
-
NIH invested $58 million to catalyze data science and health research innovation in Africa
On Jul. 27, 2020, the NIH launched a $58 million initiative to advance data science, catalyze innovation and…
-
Biotechnology | COVID-19 | NIH | Therapeutics
Onconova Therapeutics submitted application for rigosertib to participate in federally funded human studies in COVID-19 disease
On Jul. 27, 2020, Onconova Therapeutics announced that it had submitted an application with the National Institute of…
-
Preclinical study showed SARS-CoV-2 spike protein licensed by Oragenics from NIH produces neutralizing antibodies
On Jul. 22, 2020, Oragenics announced that the National Institutes of Health created stabilized pre-fusion spike protein (CoV-2…
-
Experimental coronavirus vaccine reported safe and produces immune response
On Jul. 21, 2020, researchers from the National Institutes of Health (NIH) announced that early results from the…
-
Mesa Biotech received $15.4 million funding from the NIH for accelerated scale-up and deployment
On Jul. 21, 2020, Mesa Biotech announced it had been awarded a contract up to $15.4 million from…
-
Experimental Coronavirus vaccine is safe and produced immune response
On Jul. 21, 2020, National Institutes of Health (NIH) researchers reported early results from the first COVID-19 vaccine…
-
Placenta lacks major molecules used by SARS-CoV-2 virus to cause infection
On Jul. 14, 2020, a study by NIH researchers reported the placental membranes that contain the fetus and…
-
Preliminary study suggested tuberculosis vaccine may be limiting COVID-19 deaths
On Jul. 13, 2020, researchers from Virginia Tech and the NIH suggested that Bacille Calmette-Gu�rin (BCG), a tuberculosis…
-
Neurofilament light chain outperformed other blood tests to predict and diagnose traumatic brain injury
On Jul. 9, 2020, a study from the NIH showed that neurofilament light chain (NfL) delivered superior diagnostic…
-
Long-acting injectable form of HIV prevention outperformed daily pill in NIH study
On Jul. 7, 2020, a pre-exposure prophylaxis (PrEP) regimen containing an investigational long-acting form of the HIV drug…
-
Maxim Biomedical rapid antigen COVID-19 test to deliver results in less than 15 minutes
On Jul. 2, 2020, Maxim Biomedical announced plans to produce and market as many as 3 million Maxim…
-
Complexity of human tooth enamel revealed at atomic level in NIH-funded study
On Jul. 1, 2020, National Institutes of Health (NIH) funded scientists announced using a combination of advanced microscopy…
-
NIH ACTIV vaccine working group weighed role of human challenge studies for SARS-CoV-2 vaccine development
On Jul. 1, 2020, in a Perspective for the New England Journal of Medicine, members of the NIHﾒs…
-
Biotechnology | Diagnostics | Disease | Neurology | NIH | Therapeutics
Seattle researchers teamed up to build hi-res brain map of Alzheimer’s disease
On Jun. 25, 2020, the Allen Institute announced a new a new $40.5 million collaborative research center in…
-
Universal mosquito vaccine tested
On Jun. 23, 2020, the NIH announced it had tested a ﾓuniversal mosquito vaccineﾔ known as AGS-v. It…
-
COVID-19 | Diagnostics | NIH
PathGroup selected as partner for launch of Illumina’s sequencing-nased COVID-19 diagnostic test
On Jun. 23, 2020, PathGroup announced the award of a funding grant from the National Institutes of Health…
-
The NIH halted clinical trial of hydroxychloroquine
On Jun. 20, 2020, the National Institutes of Health (NIH) announced that a clinical trial to evaluate the…
-
NIH-funded study linked endometriosis to DNA changes
On Jun. 17, 2020, DNA from uterine cells of women with endometriosis has different chemical modifications, compared to…
-
NIH launched analytics platform to harness nationwide COVID-19 patient data to speed treatments
On Jun. 15, 2020, the NIH announced it had launched a centralized, secure enclave to store and study…
-
COVID-19 | NIH | Therapeutics
NIH funded study to evaluate drugs prescribed to children with COVID-19
On Jun. 10, 2020, researchers funded by the National Institutes of Health (NIH) launched an effort to evaluate…
-
NIH study linked cigarette smoking to higher stroke risk in African Americans
On Jun. 10, 2020, African Americans who smoke are nearly 2.5 times more likely to have a stroke…
-
Biotechnology | Diagnostics | Disease | Genomics | NIH | Therapeutics
NIH researchers uncovered genes linked to common recurrent fever in children
On Jun. 8, 2020, researchers at the National Human Genome Research Institute announced they had discovered clues to…
-
Biotechnology | HIV | NIH
Just – Evotec Biologics partnered with ABL on development of broadly neutralising antibody against HIV
On Jun. 8, 2020, Evotec announced that its Seattle-based subsidiary Just – Evotec Biologics had entered into an…
